This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Fennec Pharmaceuticals Inc.
Will release its second-quarter 2025 financial results before the opening of the U.S. financial markets on Thursday, August 14. Management will host a conference call and webcast that day to discuss the Company’s financial and business results. Fennec Pharmaceuticals Inc. shares T.FEC are trading unchanged at $6.14.
